Work

Abstract 395: Identification of drug resistance factors in ALK-rearranged lung cancer using genome-wide CRISPR activation screening.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-395

Authors: Mai Nagasaka, Marie Kawahara, Ken Uchibori, Makoto Nishio, Ryohei Katayama

Institution: Japanese Foundation For Cancer Research

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7149008366

Cites:

Cited by:

Related to: 10